CClinicalTrials.gg
TerminatedNCT05249036ArCanUSUpdated Aug 15, 2024

Arterial Cannulation With Ultrasound

An interventional study of Ultrasound guided arterial cannulation and Palpation guided arterial cannulation in Perioperative/Postoperative Complications, sponsored by Queen Mary University of London. Terminated at 1 site in United Kingdom. Open to participants aged 45 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-15.

Sponsored by Queen Mary University of London · Not applicable, Interventional, and Treatment

Why this study was terminated
Primary event rate far higher than estimated for sample size calculation.
Phase
Not applicable
Study type
Interventional
Enrollment
57
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Study summary

A drop in blood pressure during anaesthesia for a surgical procedure has been associated with worse patient outcomes, including complications such as damage to the heart, brain and kidneys. Continuous blood pressure monitoring prior to the start of anaesthesia alerts the anaesthetist to drops in blood pressure and allows this to be treated promptly. This may help to avoid the complications described above.

Continuous blood pressure monitoring is carried out by inserting a small plastic tube (cannula) into an artery. In this study, the investigators propose inserting a cannula into the radial artery in the wrist before a patient is anaesthetised for surgery. The usual technique for insertion of this cannula is for the anaesthetist to identify the site of the radial artery by feeling for an arterial pulse with the fingertips (palpation). An alternative technique for identification is to use ultrasound. Ultrasound creates a two-dimensional image of the area under the skin on a screen, enabling the operator to visualise the artery being targeted. This may reduce the number of cannulation attempts required, reducing patient discomfort.

Read the detailed description

The investigators will test whether ultrasound guidance improves the success rate of radial artery cannulation, compared to palpation alone, in a randomised controlled trial in an NHS hospital. Patients will be over 45 years old, undergoing general or neuraxial anaesthesia for non-cardiac surgery lasting 120 minutes or more. Patients will be randomly assigned to a palpation or ultrasound-guided technique for arterial cannulation. Patients will receive numbing local anaesthetic cream to the area beforehand. A needle is used to introduce the cannula into the artery. There will be a maximum of one attempt allowed. In addition to measuring success rate, we will also compare whether the successfully sited cannula provides an adequate arterial waveform, requires resiting at any point during the surgery and any complications which arise directly related to arterial catheterisation. Patients will receive standard anaesthetic and surgical care in all other respects.

02

Conditions studied

  • Perioperative/Postoperative Complications

Keywords

  • Arterial cannulation
  • Ultrasound
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's enrollment of 57 is below the median of 119 across 689 interventional studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Queen Mary University of London is the lead sponsor of 250 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Patients scheduled to undergo major elective or urgent (not requiring intervention in \<24 hours) non-cardiac surgery under general anaesthesia and/or neuraxial anaesthesia, expected to take >120 minutes from induction of anaesthesia
  2. Requiring overnight hospital stay.

Exclusion criteria

Exclusion Criteria:

  1. Anatomical deformity
  2. Unable to consent
  3. Cannulation attempt within 24 hours
  4. Overlying infection
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
57 participants (actual)

Study arms

  • Experimental
    Ultrasound guided arterial cannulation

    Anaesthetist will use real-time ultrasound guidance to guide arterial cannulation

    Procedure: Ultrasound guided arterial cannulation

  • Active comparator
    Palpation guided arterial cannulation

    Anaesthetist will use palpation (standard-of-care) technique to guide arterial cannulation

    Procedure: Palpation guided arterial cannulation

Interventions

  • ProcedureUltrasound guided arterial cannulation

    Arterial cannulation will be attempted at the site of the radial artery of the non-dominant hand, using real-time ultrasound guidance

  • ProcedurePalpation guided arterial cannulation

    Arterial cannulation will be attempted at the site of the radial artery of the non-dominant hand, using palpation technique (standard-of-care)

06

What researchers measure

Primary outcomes

  1. Success rate at first attempt to cannulate the radial artery

    Success is defined as radial artery cannulation resulting in a transduced arterial waveform. First attempt is defined as one needle puncture through the skin.

    Time frame: 10 minutes

Secondary outcomes

  1. Characteristics of arterial waveform

    Assessment for presence of: (1) Dicrotic notch; (2) \>1 oscillation after fast flush; (3) \<3 oscillations after fast flush

    Time frame: Within 15 mins of catheterisation.

  2. Complications

    Recannulation required before/after surgery, infection, hematoma, thrombus.

    Time frame: 24 hours

07

Study locations

1 site
  • Royal London Hospital
    London, E1, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05249036
Lead sponsor
Queen Mary University of London
Collaborators
The London Clinic
Responsible party
Sponsor
First posted
Feb 21, 2022
Start date
Dec 25, 2021
Primary completion
Nov 30, 2023
Completion
Nov 30, 2023
Last update
Aug 15, 2024

Study contacts

Gareth L Ackland, PhD FRCA
principal investigator · Translational Medicine & Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion